The Agency for Healthcare Research and Quality (AHRQ) is a comparatively small part of the federal budget, but its research priorities for FY 2016 affect areas that consume huge sums.
Tucked within President Obama’s massive $3.99 trillion budget proposal are comparatively tiny requests for research funds into some of the most problems in healthcare, which seek answers for things like how to best treat patients with multiple chronic conditions, how to give guidance to primary care physicians facing an epidemic of prescription and opioid drug abuse. There’s even a request to track the effectiveness of the new effort to tie more Medicare payments to value instead of volume.
The Agency for Healthcare Research and Quality (AHRQ), an arm of the US Department of Health and Human Services (HHS), outlined 4 priority areas in its budget request, which appears on the HHS website. These are:
Improve healthcare quality. This area includes $12 million for an initiative to “optimize care for patients with multiple chronic conditions,” which AHRQ notes represent a growing share of both the population generally (one-fourth) and those in Medicare (two-thirds). Of great importance, two-thirds of all US healthcare spending goes to persons with multiple chronic conditions, which can include diabetes, cardiovascular disease, obesity, metabolic syndrome, or chronic obstructive pulmonary disorder, among many others. According to AHRQ, the initiative seeks to “develop, test and disseminate tools that enhance clinicians’ abilities to develop integrated care plans that fully reflect the factors and circumstances that affect patients’ efforts to manage their health.” Care models that are doing a better job than most will be studied.
The budget also seeks $5 million, including $1 million for an evidence review and $4 million for grants, to identify best practices for combatting prescription drug and opioid abuse and to bring evidence-based treatment into primary practices, especially in rural areas.
Make healthcare safer. This area builds upon current research and provides $76 million for the patient safety portfolio, including $14.5 million for ongoing grants and contracts, which have been focused on safety in hospital settings. Adverse events, including falls, drug events, pressure ulcers and hospital acquired infections have dropped 17%, saving $12 billion and resulting in 50,000 fewer deaths. Going forward, more settings will be added, including nursing homes and primary care, with another $34 million dedicated toward reducing healthcare associated infections.
Increase accessibility. As described by AHRQ, this area focuses on collecting data and evidence of the impact that changes in health insurance coverage have on people: their health and wellbeing, their finances, as well as the broader labor markets, on providers, and on the safety net. The FY 2016 budget provides $68.9 million for the Medical Expenditure Panel Survey, which AHRQ says is “the only national source for comprehensive annual data on how Americans use and pay for medical care.” At a time of increasing change in the payer mix and the delivery of care, this request seeks to collect evidence on the dynamics of these changes.
Improve healthcare affordability, efficiency, and cost transparency. A request of $1.5 million for research would produce evidence on “paying for value,” which was the subject of an HHS initiative last week. AHRQ seeks funds to track the effectiveness, “to identify types of healthcare that are amenable to strong financial incentives.”
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
COPD Mortality Falls in China, Yet High Burden Persists in Underdeveloped Regions
November 12th 2024Chronic obstructive pulmonary disease (COPD) burden remains high in underdeveloped regions of China despite a decline in related deaths, highlighting the need for targeted management and prevention strategies.
Read More